178 related articles for article (PubMed ID: 21798282)
1. Mouse strain- and age-dependent effects of binge methamphetamine on dopaminergic signaling.
Good RL; Liang LP; Patel M; Radcliffe RA
Neurotoxicology; 2011 Dec; 32(6):751-9. PubMed ID: 21798282
[TBL] [Abstract][Full Text] [Related]
2. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
Killinger BA; Moszczynska A
J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
[TBL] [Abstract][Full Text] [Related]
3. Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure.
Miller DB; O'Callaghan JP; Ali SF
Ann N Y Acad Sci; 2000 Sep; 914():194-207. PubMed ID: 11085321
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine-induced locomotor changes are dependent on age, dose and genotype.
Good RL; Radcliffe RA
Pharmacol Biochem Behav; 2011 Mar; 98(1):101-11. PubMed ID: 21163294
[TBL] [Abstract][Full Text] [Related]
5. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
[TBL] [Abstract][Full Text] [Related]
6. Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.
McFadden LM; Vieira-Brock PL; Hanson GR; Fleckenstein AE
Neuropharmacology; 2015 Jun; 93():146-54. PubMed ID: 25645392
[TBL] [Abstract][Full Text] [Related]
7. The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity.
Thomas DM; Francescutti-Verbeem DM; Kuhn DM
J Neurochem; 2008 May; 105(3):605-16. PubMed ID: 18088364
[TBL] [Abstract][Full Text] [Related]
8. A single high dose of methamphetamine increases cocaine self-administration by depletion of striatal dopamine in rats.
Xi ZX; Kleitz HK; Deng X; Ladenheim B; Peng XQ; Li X; Gardner EL; Stein EA; Cadet JL
Neuroscience; 2009 Jun; 161(2):392-402. PubMed ID: 19336247
[TBL] [Abstract][Full Text] [Related]
9. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
O'Neil ML; Kuczenski R; Segal DS; Cho AK; Lacan G; Melega WP
Synapse; 2006 Nov; 60(6):465-73. PubMed ID: 16897726
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity.
Liu B; Traini R; Killinger B; Schneider B; Moszczynska A
Exp Neurol; 2013 Sep; 247():359-72. PubMed ID: 23313192
[TBL] [Abstract][Full Text] [Related]
11. Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors.
Xu W; Zhu JP; Angulo JA
Synapse; 2005 Nov; 58(2):110-21. PubMed ID: 16088948
[TBL] [Abstract][Full Text] [Related]
12. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine.
Chapman DE; Hanson GR; Kesner RP; Keefe KA
J Pharmacol Exp Ther; 2001 Feb; 296(2):520-7. PubMed ID: 11160639
[TBL] [Abstract][Full Text] [Related]
13. Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion.
Ventura R; Alcaro A; Cabib S; Conversi D; Mandolesi L; Puglisi-Allegra S
Neuropsychopharmacology; 2004 Jan; 29(1):72-80. PubMed ID: 12968132
[TBL] [Abstract][Full Text] [Related]
14. Protein phosphorylation cascades associated with methamphetamine-induced glial activation.
Hebert MA; O'Callaghan JP
Ann N Y Acad Sci; 2000 Sep; 914():238-62. PubMed ID: 11085325
[TBL] [Abstract][Full Text] [Related]
15. Methamphetamine-induced neurotoxicity in BALB/c, DBA/2N and C57BL/6N mice.
Kita T; Paku S; Takahashi M; Kubo K; Wagner GC; Nakashima T
Neuropharmacology; 1998 Sep; 37(9):1177-84. PubMed ID: 9833648
[TBL] [Abstract][Full Text] [Related]
16. Effect of a binge-like dosing regimen of methamphetamine on dopamine levels and tyrosine hydroxylase expressing neurons in the rat brain.
Moreira da Silva Santos A; Kelly JP; Dockery P; Doyle KM
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():303-309. PubMed ID: 30296469
[TBL] [Abstract][Full Text] [Related]
17. COMT val158met genotype alters the effects of methamphetamine dependence on dopamine and dopamine-related executive function: preliminary findings.
Saloner R; Cherner M; Sundermann EE; Watson CW; Iudicello JE; Letendre SL; Kumar A; Ellis RJ
Psychiatry Res; 2020 Oct; 292():113269. PubMed ID: 32739643
[TBL] [Abstract][Full Text] [Related]
18. Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicity.
Thomas DM; Francescutti-Verbeem DM; Kuhn DM
J Neurochem; 2009 Jun; 109(6):1745-55. PubMed ID: 19457119
[TBL] [Abstract][Full Text] [Related]
19. Neurochemical and behavioral comparisons of contingent and non-contingent methamphetamine exposure following binge or yoked long-access self-administration paradigms.
Schweppe CA; Burzynski C; Jayanthi S; Ladenheim B; Cadet JL; Gardner EL; Xi ZX; van Praag H; Newman AH; Keck TM
Psychopharmacology (Berl); 2020 Jul; 237(7):1989-2005. PubMed ID: 32388619
[TBL] [Abstract][Full Text] [Related]
20. Delta opioid peptide [D-Ala2, D-Leu5]enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53.
Hayashi T; Hirata H; Asanuma M; Ladenheim B; Tsao LI; Cadet JL; Su TP
Synapse; 2001 Mar; 39(4):305-12. PubMed ID: 11169780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
